Copyright
©The Author(s) 2025.
World J Stem Cells. Mar 26, 2025; 17(3): 98911
Published online Mar 26, 2025. doi: 10.4252/wjsc.v17.i3.98911
Published online Mar 26, 2025. doi: 10.4252/wjsc.v17.i3.98911
Figure 6 Targeting fat mass and obesity-associated alleviates enthesitis-related new bone formation in ankylosing spondylitis animal models.
A: Histological analysis of bone formation in the enthesis was performed using hematoxylin and eosin (HE) staining and Safranin O. Scale bar = 500 μm (upper) or 250 μm (lower) (n = 5); B: The proposed model shows upregulation of fat mass and obesity-associated in mesenchymal stem cells leads to defects in osteoclastogenesis in ankylosing spondylitis via the long non-coding RNA activated by DNA damage/miR-4284 axis. HE: Hematoxylin and eosin; FTO: Fat mass and obesity-associated; Av-NC: Adeno-associated virus of negative control; Av-shFTO: Adeno-associated virus of short hairpin RNA targeting fat mass and obesity-associated; NORAD: Non-coding RNA activated by DNA damage.
- Citation: Liu WJ, Wang JX, Li QF, Zhang YH, Ji PF, Jin JH, Zhang YB, Yuan ZH, Feng P, Wu YF, Shen HY, Wang P. Fat mass and obesity-associated protein in mesenchymal stem cells inhibits osteoclastogenesis via lnc NORAD/miR-4284 axis in ankylosing spondylitis. World J Stem Cells 2025; 17(3): 98911
- URL: https://www.wjgnet.com/1948-0210/full/v17/i3/98911.htm
- DOI: https://dx.doi.org/10.4252/wjsc.v17.i3.98911